Searched for
BIOCON STOCK NEWS
West Bengal's electronics factory push; Fed jitters hit TCSWest Bengal is exploring ways to expand electronics manufacturing under EMC 2.0. This and more in today's ETtech Top 5.- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Stocks in news: BSE, Britannia, Paytm, Meesho, RILIndian markets showed resilience, climbing despite volatility, buoyed by positive global trends and falling crude oil prices. Analysts anti...
- Stocks in news: Paytm, Bajaj Auto, L&T, Bharti Airtel, Hero MotoCorpMarkets closed lower amid global headwinds and geopolitical worries. Several companies like Paytm, Bajaj Auto, and L&T are in focus due to ...
- Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...
- Stocks in news: TCS, HDFC Bank, ITC Hotels, Hyundai India, Adani EnterprisesMarkets surged for the fourth consecutive session, buoyed by favorable geopolitical cues. Key stocks like TCS, HDFC Bank, ITC Hotels, Hyund...
- Biocon shares in focus after subsidiary launches biosimilar alternative to Stelara in the USBiocon Biologics has launched YESINTEK, a biosimilar to Stelara, in the United States for treating chronic autoimmune conditions, offering ...
- HSBC sees Biocon share price rallying up to Rs 430; stock surges 5%Biocon Ltd shares rose 4.7% after HSBC upgraded its rating to "buy" and raised the target price to Rs 430. The upgrade reflects a turnaroun...
- Buy Biocon, target price Rs 390: Axis SecuritiesBiocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 40868.42 Crore) operating in Pharmaceuticals ...
- Buy Biocon, target price Rs 370: Anand RathiBiocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 37404.69 Crore) operating in Pharmaceuticals ...
- Buy Biocon, target price Rs 340: Anand RathiBiocon Ltd. key Products/Revenue Segments include Bio Pharmaceuticals, Other Operating Revenue, Waste and Sale of services for the year end...
- Biocon drops 4% as USFDA issues form 483 for 3 sitesAs per the US Food and Drug Administration (USFDA), Form 483 is issued to a firm's management at the conclusion of an inspection when an in...
- Hold Biocon, target price Rs 380: ICICI DirectBiocon, incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 44314.15 crore) operating in Pharmaceuticals secto...
- Viatris deal pinches Biocon, but may prove a good betThe $3.3-billion acquisition - that includes $2.3 billion cash and a 12.9% equity stake in BBL - stands at over half of the market cap of B...
- Biocon shares drop after French regulator finds lapses at its plantANSM has raised deficiencies concerning two biosimilar products intended in the treatment of cancer and one intended for diabetes.
- D-Street may be ignoring Biocon’s growth risksThe stock price has priced in all the near-term positives arising from the business — leaving little room for any risks.
- Biocon to stay buoyant going forward: Mehraboon IraniBullish on Biocon, recommend it even now before a dip: Mehraboon Irani.
- Biocon enters in partnership with Bristol-Myers Squibb; stock upThe stock has been in an uptrend this week and has moved nearly 5% higher, while for the month of November Biocon surged over 16%.
- Biocon can move up another 6% to 8%: Ambareesh BaligaThose who have been holding on to this stock for a long time, it has been a bit of a underperformer if you see in the last 1-1.5 years. So ...
Load More
